Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4

Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Jan 22, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new light therapy device to help treat severe brain bleeding, known as intraventricular hemorrhage (IVH), in premature babies. Specifically, it focuses on babies who have grade 3 or 4 IVH, which are the more serious levels of this condition. The study aims to see if the treatment is safe, how well it works, and how parents feel about it. Researchers plan to treat 12 to 24 newborns using a special light for a short time each day over 12 days. They will also check in with parents at 6 and 12 months to see how the babies are developing.

To be eligible for the trial, babies must be under 1 month old and diagnosed with grade 3 or 4 IVH. This means that if a baby has less severe bleeding or is older than 1 month, they won't be able to participate. Families who choose to take part in the study can expect regular visits for treatment and follow-up calls to monitor their child’s progress. This trial is an important step in understanding how to best help babies with this serious condition, and it will help shape future research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • neonates with intraventricular hemorrhage grade 3 or 4 less than 1 month old.
• Exclusion Criteria:
• • neonates without IVH grade 3/4 or older than 1 month.